Title : Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial.

Pub. Date : 2001 Mar 13

PMID : 11245644






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The role of enhanced antiplatelet protection through pretreatment with the platelet ADP-receptor antagonist ticlopidine in preventing both the early and late complications of coronary stenting has not previously been explored. Ticlopidine purinergic receptor P2Y12 Homo sapiens